Eli Lilly Canada, Inc announced today that Jaypirca® (pirtobrutinib, 100 mg & 50 mg tablets) is now approved and available for use as monotherapy for the treatment of adult patients in Canada with: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results